Phase II Trial of Locally Advanced/Metastatic Soft Tissue Sarcoma or Advanced/Metastatic Malignant GIST

PHASE2CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

April 30, 2010

Study Completion Date

March 31, 2011

Conditions
SarcomaMalignant Gastrointestinal Stromal Tumor
Interventions
DRUG

Gemcitabine , Docetaxel

Gemcitabine 800 mg/m2 IV over 80 minutes on day 1 and day 8, and Docetaxel 60 mg/m2 IV over 60 minutes on day 1 of a 21-day cycle

Trial Locations (1)

Unknown

China Medical University Hospital, Taichung

All Listed Sponsors
collaborator

Mackay Memorial Hospital

OTHER

collaborator

Tri-Service General Hospital

OTHER

collaborator

China Medical University Hospital

OTHER

collaborator

Kaohsiung Veterans General Hospital.

OTHER

collaborator

Taichung Veterans General Hospital

OTHER

collaborator

Buddhist Tzu Chi General Hospital

OTHER

lead

National Health Research Institutes, Taiwan

OTHER

NCT00359333 - Phase II Trial of Locally Advanced/Metastatic Soft Tissue Sarcoma or Advanced/Metastatic Malignant GIST | Biotech Hunter | Biotech Hunter